Atrás
Precio Healios K.K. (HLOSF)
Gráfico del Precio de Acciones HLOSF
HLOSF Dividendos
Healios K.K.
$2.1
0%
$0
Al cierre: Jan 27, 16:00:00 GMT-5
$2.1
0%
$0
Mercado Posterior: Jan 27, 18:22:26 GMT-5
Sin datos aúnEstadísticas clave
Cierre Anterior
$2.1
Precio de apertura
$2.1
Rango del día
$2.1 - $2.1
Rango de 52 semanas
$0.96 - $4.45
Volumen
200
Volumen promedio
153
EPS (TTM)
-0.38
Rendimiento de dividendos
--
Cap. de mercado
$242.3M
¿Qué es HEALIOS K K?
Healios KK engages in the research, development, and sale of cellular and regenerative medicine. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 65 full-time employees. The company went IPO on 2015-06-16. The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved